Kathy Wood goes on a record-breaking buying spree as she stocks up on Tesla and other stocks during immense dip in the market find out more in today's video Kathy Wood goes bargain hunting three stocks she just bought Kathy woodbox shares of coinbase Tesla and Verve Therapeutics on Wednesday coinbase and Tesla have fallen sharply in recent months wood has shown a tendency to buy when her largest Holdings take a dip Verve Therapeutics has gone the other way roughly doubling after striking a potentially lucrative partnership for


its gene editing platform this summer the growth focused money manager is making moves Kathy Wood is hoping to catch 2020 in a bottle again the co-founder of CEOs and Lead stock picker of Arc invest delivered jaw-dropping returns two years ago across her family of funds but her stock picking skills have proven mortal in 2021 and 2022 can she get back on track in 2023 what added to just a couple of her positions on Wednesday coinbase Tesla and Verve Therapeutics are three of the four stocks that are parkinvest was buying


yesterday let's take a closer look at our shopping cart what is a buy the dip mentality for some of her largest Holdings and that's certainly the case for coinbase she has been nibbling on the leading cryptocurrency trading platform lately with the shares 89 below the all-time highs they reached 13 months ago coinbase hit another all-time low on Tuesday this year has certainly been a tumultuous one for crypto prices for most digital currencies have plummeted and the down decks have intensified as


once popular cryptocurrency platforms including FTX and Celsius Network have collapsed coinbase can rightfully argue that it has a strong balance sheet and doesn't engage in the risky business practices of its Fallen peers but with Regulators starting to crack down on the industry and crypto prices diving it's hard to make a living as a trading platform coinbase CEO Brian Armstrong said that Revenue will be less than half the 7.8 billion dollars recorded last year in a recent interview with Bloomer


the implication in last week's interview is that the current quarter will be rough if you're looking for a silver lining Key Bank analyst Alex markgraph initiated coverage of the stock with a sector weight rating on Monday a neutral Market call may not seem very inspiring but it's a welcome break from the flurry of downgrades and price targets slashing that we've seen over the past few months remember when folks thought that Elon must pay too much when he and his fellow investors shelled out 44 billion for


Twitter real pain is being felt by Tesla investors as that stock is seeing its market cap surrender 215 billion dollars in value since the Twitter deal closed on August 27th you can say that the two data points aren't related but Tesla's CEO has become a more polarizing figure since amplifying his voice with controversial tweets on the social media platform he now owns Tesla didn't help its own fortunes with a poorly received quarterly report just a couple of days before closing on the Twitter deal sales


are still growing but the Market's concerned with Rising inventory levels and the eroding of gross margin remember when you had to wait months for a new Tesla you can still order a model 3 or a model y today with an estimated delivery by the month's end Verve Therapeutics Arc invest has taken a shine to Verve Therapeutics this month it has added to its state for eight consecutive trading days some days has been the only position or just one of two positions that what is added to her portfolios


what makes Verve so special it's developing a gene editing platform that works inside the body it will initially tackle liver diseases its League candidate is verve 101 aiming to lower low density lipoprotein LDL cholesterol the so-called bad cholesterol by silencing the protein that limits the liver's ability to handle LDL cholesterol early stage treatment developers are risky with high potential upside beyond the substantial losses Verve has yet to generate any kind of meaningful Revenue


however the stock has more than doubled since bottoming out in June it received industry affirmation over the summer after striking a deal with vertex Pharmaceuticals a four-year Arrangement where the two companies will partner on a gene editing approach that will tackle an undisclosed liver disease it can result as in as much as 406 million dollars in Milestone payments and royalties for perfect pans out that's a good chunk of change for Verve Therapeutics with its current 1.4 billion dollars market cap


coin based Tesla and Verve Therapeutics are all trading well below their Highs but they're all still compelling growth stocks now it's time to see if investors will be partying like it's 2020 with Arc invest in 2023 is North America's largest electric vehicle EV manufacturer headed for another breakdown in 2023 over the trailing decade no S and P 500 company has delivered a juicy return for its shareholders an electric vehicle EV manufacturer Tesla investors who placed their faith in the company and its CEO


Elon Musk have been rewarded with a return of just above seven thousand percent in a decade but even top performing stocks hit rough patches when the closing bell rang on Deck 12 2022 shares of North America's leading EV company were lower by 52 why ear to date the 64 000 question is does a more than having in value make Tesla a buy to answer that you have to understand why shares fell in the first place as well as dig into what catalysts and challenges lie ahead Wall Street hit the brakes on Tesla stock in 2022


there's no single factor to blame that would neatly explain Tesla's troubles this year rather it's been a Confluence of factors to begin with the Cavite 19 pandemic has wreaked havoc on the supply chain for automakers Tesla's sham High gigafactory in China has had its production adversely impacted by provincial lockdowns meanwhile semiconductor chip and general part shortages have slowed or delayed output another problem for Tesla has been historically High inflation and the federal reserve's


monetary policy shift to combat that inflation Tesla is contending with soaring material costs and higher rates could make it less likely that consumers are willing to spend big bucks on a new EV bear Market sentiment has done the company no favors either it's not uncommon for investors to give greater weight to traditional valuation metrics when the broader Market has endured a sizable decline entering the year Tesla was well above a triple digit price to earnings P slash e ratio in an industry


known for high single digit p e ratios lastly Elon Musk deserve some of the blame must acquisition of social media platform Twitter has been a distraction for much of the year to add he was required to sell billions of dollars of Tesla stock to provide the needed liquidity to finance the Twitter buyout Insider selling will sometimes benign can send the wrong signal to investors what does 2023 hold in store for Tesla now that you have a better understanding of why Tesla stock had the skids in 2022


let's look ahead to what catalysts might feel the company's sales growth and bottom line in 2023 arguably the biggest catalyst is the continued ramp up of the two new gigafactories that came online earlier this year in Berlin Germany and Austin Texas Tesla is on Pace to surpass 1 million deliveries for the first time in its history in 2022 and has a real opportunity to lift production to north of 1.5 million EV in 2023 assuming domestic and Global Supply chains cooperate model expansion is another potential


growth and valuation driver in the upcoming year the Tesla semi which was unveiled in late 2017 began production in October with deliveries beginning this month Additionally the much-awaited Cyber truck is expected to begin mass production sometime in late 2023 the Cyber truck has a healthy order backlog And Timely production could lead to a surge in operating cash flow in late 2023 or perhaps early 2024. the new year also brings with it an opportunity for must to find a new CEO for Twitter Tesla's shareholders would certainly


appreciate much devoting more of his time to overseeing things at the world's most valuable automaker instead of trying to turn around an underperforming social media platform lastly all eyes will be on Tesla's operating margin which could benefit from a variety of cost reductions or credits in particular the inflation reduction act era will provide consumers with a 7 500 credit assuming Tesla's batteries meet the conditions set forth in the ira is Tesla a stock to consider buying Tesla is now navigated through


the headwinds that sacked the stock in 2022 as well as the biggest catalysts awaiting the company in 2023 it's time to return to the all-important question with shares down 52 this year is it time to buy Tesla to be perfectly blunt my answer is no although production is picking up at the company's Berlin and awesome gear factories and the IRA provides added incentive for consumers to purchase an EV the single greatest liability for Tesla in the new year has nothing to do withhttps://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-6487850291212435 its production and everything to do


with its CEO to many musk is a Visionary as CEO he helped build Tesla from the ground up to mass production which is something no other automaker had done in over a half century but he's a distraction and liability that'll be hard for Tesla to overcome putting aside the fact that musk has drawn the ire of Securities Regulators on more than one occasion his biggest issue is over-promising and under delivering for example level 5 full self-driving has been promised as being one year away since 2014 and the company is no closer


to mastering autonomous driving now than it was back then the expected production of the semi and cyber truck were also delayed by years although musk promises are baked into Tesla's valuation rarely if ever do those promises come to fruition that's a problem for a richly valued automaker the other issue recognizes Tesla isn't immune to the challenges facing the Auto industry ongoing supply chain issues are bad news for all automakers and not just its competitors that makes its nosebleed P


slash e-ratio all the more avoidable now and in 2023